Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5029)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2021 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang B, Sun X, Huang KJ, Zhou LS, Qiu ZJ. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis. World J Gastroenterol 2021; 27(17): 1993-2014 [PMID: 34007135 DOI: 10.3748/wjg.v27.i17.1993] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/1993.htm |
| Number | Citing Articles |
| 1 |
Sumei Li, Fengru Jiang, Feiyu Chen, Yinzhao Deng, Haiying Huang. Silencing long noncoding RNA LINC01133 suppresses pancreatic cancer through regulation of microRNA‐1299‐dependent IGF2BP3. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23534
|
| 2 |
Tianying Zheng, Wenfei Han, Aijun Wang, Yonggang Wang. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. PeerJ 2022; 10: e12802 doi: 10.7717/peerj.12802
|
| 3 |
Ghaidaa Raheem Lateef Al-Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, Firas Rahi Alhachami, Shukhrat Ziyadullaev, Mahmoud Kandeel, Roua Abulkassim, R Sivaraman, Noora M Hameed, Rosario Mireya Romero Parra, Sajad Karampoor, Rasoul Mirzaei. The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancer. Future Oncology 2022; 18(38): 4209 doi: 10.2217/fon-2022-0574
|
| 4 |
Jingyun Liu, Mengyue Wang, Miaowen Wang, Fu Wang, Beilei Zhang. LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma. Biochemical Genetics 2024; 62(1): 485 doi: 10.1007/s10528-023-10435-4
|
| 5 |
Waleed Hassan Almalki. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer. Pathology - Research and Practice 2023; 251: 154852 doi: 10.1016/j.prp.2023.154852
|
| 6 |
Yiming Liu, Xinyang Hu, Shiyao Liu, Sining Zhou, Zhi Chen, Hongchuan Jin. Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.783860
|
| 7 |
Lin Lin, Liang Xiao, Chang'e Jin, Ying Qin, Haoyuan Deng, Meixiang Li, Huan Lin, Xuehao Gong. Circ_0058058 Drives the Malignant Phenotypes and Immune Evasion of Pancreatic Cancer by the MicroRNA-557–Dependent Regulation of PDL1. Pancreas 2022; 51(10): 1444 doi: 10.1097/MPA.0000000000002205
|
| 8 |
Jingjing Zhu, Ke Wu, Shuai Liu, Alexandra Masca, Hua Zhong, Tai Yang, Dalia H Ghoneim, Praveen Surendran, Tanxin Liu, Qizhi Yao, Tao Liu, Sarah Fahle, Adam Butterworth, Md Ashad Alam, Jaydutt V Vadgama, Youping Deng, Hong-Wen Deng, Chong Wu, Yong Wu, Lang Wu. Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma. GigaScience 2024; 13 doi: 10.1093/gigascience/giae012
|
| 9 |
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, Shayan Fallah, Arezoo Sanaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Shamin Rezaei, Hajar Heidari, Mitra Behroozaghdam, Salman Daneshi, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi, Saeed Samarghandian. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy 2022; 154: 113609 doi: 10.1016/j.biopha.2022.113609
|
| 10 |
Wei Zhang, Tingting Jiang, Keping Xie. Epigenetic reprogramming in pancreatic premalignancy and clinical implications. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1024151
|
| 11 |
Jichuan Xu, Jian Xu, Xinyuan Liu, Jianxin Jiang. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01061-x
|
| 12 |
Mahsa Saliani, Amin Mirzaiebadizi, Niloufar Mosaddeghzadeh, Mohammad Reza Ahmadian. RHO GTPase-Related Long Noncoding RNAs in Human Cancers. Cancers 2021; 13(21): 5386 doi: 10.3390/cancers13215386
|
| 13 |
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023; 27: 101579 doi: 10.1016/j.tranon.2022.101579
|
| 14 |
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01813-y
|